Abstract:Key PointsPhenotypic screening has been one of the most effective approaches to drug discovery, but only a subset of disease-associated phenotypes can be modelled in cultured cells. Zebrafish exhibit a much broader range of disease-associated phenotypes, including disorders of physiology, metabolism and behaviour, while retaining the ability to be used for high-throughput applications.Zebrafish are phylogenetically more distant from humans than rodents are, but they possess orthologues of 82% of human disease-associated genes. In many cases, they exhibit physiological and pharmacological conservation that approaches (and occasionally surpasses) that of rodents.Zebrafish screens have discovered a few compounds that have made it to advanced preclinical and clinical trials, including new compound classes and repurposed drugs.Zebrafish have been used in several toxicology applications, including the screening of large compound collections for potential liabilities.Although target identification remains a challenge for phenotype-based small-molecule discovery, rich databases of zebrafish phenotypes have facilitated the identification of targets for several small molecules.Rapid advances in genome editing and high-throughput phenotyping point to promising new applications for zebrafish in drug discovery over the coming years, including the discovery of compounds that suppress disease phenotypes associated with specific human mutations.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the effectiveness and relevance of zebrafish as a drug discovery tool. Specifically, the paper focuses on the following aspects: 1. **The Revival of Phenotypic Screening in Drug Discovery**: The paper points out that phenotypic - based screening methods have been replaced by target - based screening methods in the past 30 years, but in recent years, phenotypic - based screening methods have regained attention. This screening method can discover new "first - in - class drugs", which do not rely on known targets when discovered. 2. **Advantages of Zebrafish in Phenotypic Screening**: As a model organism, zebrafish has multiple advantages, including: - **A Wide Range of Biological Processes**: Zebrafish embryos or larvae can simulate complex biological processes, such as pain, sedation, tumor metastasis, vascular tone, and intestinal motility, which are difficult to observe in cell culture systems. - **Early Toxicity Insights**: Compared with cell lines, zebrafish can provide more information about compound absorption, distribution, metabolism, excretion, and toxicity. - **High - Throughput Screening**: Zebrafish can be used for large - scale screening in multi - well plates, which is suitable for high - throughput experiments. 3. **The Relevance of Zebrafish to Human Biology**: Although zebrafish are evolutionarily distant from humans, they show physiological characteristics similar to humans in many aspects, including organ systems, drug metabolism, and pharmacological effects. For example, the cardiac electrophysiology of zebrafish is more similar to that of humans than to that of rodents. 4. **Success Stories**: The paper lists several successful cases of drugs or compounds discovered through zebrafish screening, such as: - **Prohema**: A stable derivative of prostaglandin E2, used to increase the number of hematopoietic stem cells, and is currently in clinical trials. - **Dorsomorphin**: A bone morphogenetic protein (BMP) receptor inhibitor, used to treat fibrodysplasia ossificans progressiva (FOP) and inflammatory anemia. - **PROTO - 1**: A benzothiophene carboxamide, used to prevent antibiotic - induced hearing loss. In conclusion, this paper aims to explore the potential and advantages of zebrafish in drug discovery, and illustrate its application prospects in discovering new drugs and re - using existing drugs through specific examples.

Zebrafish as tools for drug discovery

In vivo drug discovery in the zebrafish

Zebrafish As a Model System for Drug Target Screening and Validation

Animal models of human disease: zebrafish swim into view

Zebrafish Model in Drug Safety Assessment

Zebrafish: An Emerging Model System for Human Disease and Drug Discovery

Application of zebrafish models in drug screening]

Application of zebrafish to safety evaluation in drug discovery

Zebrafish: An emerging model system to study liver diseases and related drug discovery

Zebrafish: a predictive model for assessing drug-induced toxicity

Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish

Screening drugs for myocardial disease in vivo with zebrafish: an expert update

Zebrafish as a Successful Animal Model for Screening Toxicity of Medicinal Plants

Zebrafish as an animal model for biomedical research

Use of Zebrafish Models to Boost Research in Rare Genetic Diseases

Zebrafish as a Model for Cardiovascular and Metabolic Disease: The Future of Precision Medicine

The Zebrafish As a Model for Human Disease

Using zebrafish to assess the impact of drugs on neural development and function

From Omics to Drug Metabolism and High Content Screen of Natural Product in Zebrafish: A New Model for Discovery of Neuroactive Compound

Zebrafish: Speeding Up the Cancer Drug Discovery Process.

Zebrafish (Danio rerio) as a model organism for screening nephrotoxic chemicals and related mechanisms